Platform
Features
0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Industries
Headquarters
Employees
Links
Stephen J. Russell
5 members
4 members
Genentech
150 followers
Formation Bio
2 followers
Illumina
67 followers
Agilent Technologies
63 followers
Cytiva
10 followers
Avantor
Promega
8 followers
United Therapeutics
7 followers
Calico
6 followers
Sage Therapeutics
5 followers
Repligen
4 followers
Explore companies